Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway

Abstract Background Bupi Yishen Formula (BYF), a patent traditional Chinese medicine (TCM) formulation, has been used in the clinical treatment of chronic kidney disease (CKD). However, the mechanism of action of BYF has not been fully elucidated. Method To investigate the variation in the metabolic...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yenan Mo, Xina Jie, Lixin Wang, Chunlan Ji, Yueyu Gu, Zhaoyu Lu, Xusheng Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-08-01
coleção:	BMC Complementary Medicine and Therapies
Assuntos:	Chronic kidney disease Bupi Yishen formula Metabolomics Kynurenic acid Aryl hydrocarbon receptor pathway
Acesso em linha:	https://doi.org/10.1186/s12906-021-03376-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!